Withdrawal of Registration Statement (rw)
March 23 2016 - 5:26PM
Edgar (US Regulatory)
CV Sciences, Inc.
2688 South Rainbow Boulevard, Suite B
Las Vegas, Nevada 89146
March 23, 2016
VIA EDGAR AND OVERNIGHT COURIER
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
|
|
Jeffrey P. Riedler
Daniel Greenspan
Christina De Rosa
|
Re:
|
|
CV Sciences, Inc. (formerly CannaVEST
Corp.)
Withdrawal of Registration Statement
on Form S-1
Filed on July 20, 2015
File No. 333-205758
|
Ladies and Gentlemen:
On behalf of CV Sciences,
Inc., a Delaware corporation (“
Company
”), we hereby request, pursuant to Rule 477 of the Securities Act
of 1933, as amended (“
Securities Act
”), that the Registration Statement on Form S-1, together with all
exhibits and amendments thereto (File No. 333-205758), as initially filed with the Securities and Exchange Commission (“
Commission
”)
on July 20, 2015 (collectively, “
Registration Statement
”) be withdrawn effective immediately. The Company
is seeking withdrawal of the Registration Statement to pursue other financing options. The Company confirms that no securities
have been sold pursuant to the Registration Statement and that the Registration Statement has not been declared effective by the
Commission.
In accordance with
Rule 457(p) of the Securities Act, the Company requests that all fees paid to the Commission in connection with the filing of the
Registration Statement be credited for future use.
Accordingly, we request
that the Commission issue an order granting the withdrawal of the Registration Statement (“
Order
”) effective
as of the date hereof or at the earliest practicable date hereafter. Please provide a copy of the Order to John Cleary, Esq. of
Procopio, Cory, Hargreaves & Savitch LLP, via email at john.cleary@procopio.com or via facsimile at (619) 744-5459.
Should you have any questions regarding
this request for withdrawal, please contact John Cleary of Procopio, Cory, Hargreaves & Savitch LLP by telephone at (619) 515-3221.
Very truly yours,
/s/ Joseph Dowling
Joseph Dowling
Chief Financial Officer
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
CV Sciences (QB) (USOTC:CVSI)
Historical Stock Chart
From Apr 2023 to Apr 2024